Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?-Reference-Cited by-同舟云学术

Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?

Published:2022-09 Issue:9 Volume:34 Page:e369-e376
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Abraham A.G.,Joseph K.^ORCID,Spratlin J.L.,Zebak S.^ORCID,Alba V.,Iafolla M.,Ghosh S.^ORCID,Abdelaziz Z.,Lui A.,Paulson K.,Bedard E.,Chua N.,Tankel K.,Koski S.^ORCID,Scarfe A.,Severin D.,Zhu X.,King K.^ORCID,Easaw J.C.,Mulder K.E.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference29 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Epidemiologic risk factors for esophageal cancer development;Mao;Asian Pac J Cancer Prev,2011

3. Epidemiology of esophageal cancer;Zhang;World J Gastroenterol,2013

4. Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study;van Meerten;Br J Cancer,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-disciplinary management of esophageal carcinoma: Current practices and future directions;Critical Reviews in Oncology/Hematology;2024-05

2. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy;Journal of Cachexia, Sarcopenia and Muscle;2024-04-13

3. Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer;European Journal of Surgical Oncology;2024-03

4. Management of esogastric cancer in older patients;Therapeutic Advances in Medical Oncology;2024-01

5. Esophageal Adenocarcinoma: One Size Might Not Fit All;The Annals of Thoracic Surgery;2023-09